KATHERINE FILBECK: Open Payments
NPI 1538597612 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 51 payments from 14 companies in 2025. Trend: 2023 $1,183 · 2024 $1,845 · 2025 $2,266
Food & beverage: $2,255Education: $11
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $486 |
| AstraZeneca Pharmaceuticals LP | 6 | $433 |
| Vanda Pharmaceuticals Inc. | 7 | $306 |
| Otsuka America Pharmaceutical, Inc. | 3 | $157 |
| Amgen Inc. | 2 | $157 |
| Janssen Biotech, Inc. | 2 | $156 |
| Lilly USA, LLC | 2 | $135 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 3 | $82 |
| Lundbeck LLC | 2 | $68 |
Products named: VRAYLAR, FANAPT, AIRSUPRA, REXULTI, TREMFYA, BREZTRI, KRYSTEXXA, MOUNJARO.
Industry payments across HI — which companies pay providers there.
